Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

1.

Epigenetics: rethinking of drug research and development.

Lundstrom K.

Future Med Chem. 2019 Nov 19. doi: 10.4155/fmc-2019-0174. [Epub ahead of print] No abstract available.

PMID:
31741399
2.

Self-amplifying RNA virus vectors: clinical applications in cancer drug delivery.

Lundstrom K.

Expert Opin Drug Deliv. 2019 Oct;16(10):1027-1029. doi: 10.1080/17425247.2019.1653851. Epub 2019 Aug 12. No abstract available.

PMID:
31387406
3.

Gene Therapy Today and Tomorrow.

Lundstrom K.

Diseases. 2019 Apr 28;7(2). pii: E37. doi: 10.3390/diseases7020037.

4.

Plasmid DNA-based Alphavirus Vaccines.

Lundstrom K.

Vaccines (Basel). 2019 Mar 8;7(1). pii: E29. doi: 10.3390/vaccines7010029. Review.

5.

RNA Viruses as Tools in Gene Therapy and Vaccine Development.

Lundstrom K.

Genes (Basel). 2019 Mar 1;10(3). pii: E189. doi: 10.3390/genes10030189. Review.

6.

Self-Replicating RNA Viruses for RNA Therapeutics.

Lundstrom K.

Molecules. 2018 Dec 13;23(12). pii: E3310. doi: 10.3390/molecules23123310. Review.

7.

Constructing RNA Viruses for Long-Term Transcriptional Gene Silencing.

Baltusnikas J, Satkauskas S, Lundstrom K.

Trends Biotechnol. 2019 Jan;37(1):20-28. doi: 10.1016/j.tibtech.2018.07.015. Epub 2018 Aug 18. Review.

PMID:
30131184
8.

Viral Vectors in Gene Therapy.

Lundstrom K.

Diseases. 2018 May 21;6(2). pii: E42. doi: 10.3390/diseases6020042. Review.

9.

Latest development on RNA-based drugs and vaccines.

Lundstrom K.

Future Sci OA. 2018 May 4;4(5):FSO300. doi: 10.4155/fsoa-2017-0151. eCollection 2018 Jun. Review.

10.

Epigenetics, Nutrition, Disease and Drug Development.

Lundstrom K.

Curr Drug Discov Technol. 2018 Apr 19. doi: 10.2174/1570163815666180419154954. [Epub ahead of print]

PMID:
29692252
11.

Long-Term Transcriptional Gene Silencing by RNA Viruses.

Baltusnikas J, Satkauskas S, Lundstrom K.

Trends Biochem Sci. 2018 Jun;43(6):397-401. doi: 10.1016/j.tibs.2018.03.003. Epub 2018 Apr 11. Review.

PMID:
29655511
12.

New frontiers in oncolytic viruses: optimizing and selecting for virus strains with improved efficacy.

Lundstrom K.

Biologics. 2018 Feb 9;12:43-60. doi: 10.2147/BTT.S140114. eCollection 2018. Review.

13.

Interaction of Plant Extracts with Central Nervous System Receptors.

Lundstrom K, Pham HT, Dinh LD.

Medicines (Basel). 2017 Feb 23;4(1). pii: E12. doi: 10.3390/medicines4010012. Review.

14.

Immunogenicity of virus-like Semliki Forest virus replicon particles expressing Indian HIV-1C gag, env and polRT genes.

Ajbani SP, Velhal SM, Kadam RB, Patel VV, Lundstrom K, Bandivdekar AH.

Immunol Lett. 2017 Oct;190:221-232. doi: 10.1016/j.imlet.2017.08.019. Epub 2017 Aug 26.

PMID:
28851629
15.

Application of Alphaviral Vectors for Immunomodulation in Cancer Therapy.

Zajakina A, Spunde K, Lundstrom K.

Curr Pharm Des. 2017;23(32):4906-4932. doi: 10.2174/1381612823666170622094715. Review.

PMID:
28641531
16.

G-protein-coupled receptor-based drugs rediscovered.

Lundstrom K.

Future Med Chem. 2017 May;9(7):633-636. doi: 10.4155/fmc-2017-0045. Epub 2017 May 15. No abstract available.

PMID:
28504914
17.

Oncolytic Alphaviruses in Cancer Immunotherapy.

Lundstrom K.

Vaccines (Basel). 2017 Apr 12;5(2). pii: E9. doi: 10.3390/vaccines5020009. Review.

18.

Alphavirus-Based Vaccines.

Lundstrom K.

Methods Mol Biol. 2017;1581:225-242. doi: 10.1007/978-1-4939-6869-5_13.

PMID:
28374252
19.

Epigenetics: new possibilities for drug discovery.

Lundstrom K.

Future Med Chem. 2017 Apr;9(5):437-441. doi: 10.4155/fmc-2017-0015. Epub 2017 Mar 31. No abstract available.

20.

Cell-impedance-based label-free technology for the identification of new drugs.

Lundstrom K.

Expert Opin Drug Discov. 2017 Apr;12(4):335-343. doi: 10.1080/17460441.2017.1297419. Epub 2017 Mar 1. Review.

PMID:
28276704

Supplemental Content

Loading ...
Support Center